CDIX · Cardiff Lexington Corp
Substantial doubt about the company's ability to continue as a going concern.
“We have sustained operating losses since inception and have an accumulated deficit of $85,617,319 as of June 30, 2026 and have a negative cash flow from operations of $668,649 for the six months ended June 30, 2026. These factors raise a substantial doubt about our company's ability to continue as a going concern.”View the 10-Q filed Aug 12, 2026
Price & Indicators
Raw chart and full-history price indicators begin at the captured split on Jan 12, 2026; bars on opposite sides are not compared.
The closing range begins at the captured split on Jan 12, 2026.
Up next
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders SellIllustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Medical Care Facilities — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
CDIX
this stock
Cardiff Lexington Corp
|
$3.91M | — | +39.5% | — | 0.0% |
|
HCA
HCA Healthcare, Inc.
|
$92.69B | -10.5% | +7.1% | 14.4 | 2.8% |
|
FSNUY
Fresenius SE & Co. KGaA
|
$30.05B | -6.9% | — | — | 0.0% |
|
THC
Tenet Healthcare Corp
|
$21.48B | +34.3% | +0.9% | 10.3 | 3.1% |
|
FMS
Fresenius Medical Care AG
|
$12.29B | -3.0% | +5.9% | — | 0.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
Raw-price comparisons begin at the captured split on Jan 12, 2026; windows that need an earlier baseline remain unavailable.
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| CDIX | -20.1% | -73.2% | -95.0% | -66.0% | — |
| SPY | +0.5% | +3.0% | +13.4% | +3.0% | +12.8% |
| vs SPY | -20.5% | -76.1% | -108.5% | -69.0% | — |